Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
Centre Oscar Lambret
Seagen Inc.
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Kivu Bioscience Inc.
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Eli Lilly and Company
Neonc Technologies, Inc.
ViroMissile, Inc.
Rutgers, The State University of New Jersey
Arcus Biosciences, Inc.
Terremoto Biosciences Inc.
Bristol-Myers Squibb
Kaiser Permanente
Sichuan Enray Pharmaceutical Sciences Company
AstraZeneca